UTI Healthcare Fund Direct-Growth
NAV
₹328.4621
as on 17 Nov 2025, 11:12 PM
₹0.6464(0.20%)
Last Change
Schemes Managed By
Scheme Information
UTI Healthcare Fund Direct-Growth
as of 31 Oct 2025, 05:30 AM
₹1,124.88 Cr
1.31%
1.87%
Open-End
Growth
Exit load of 1% if redeemed within 30 days.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
98.12%
₹1,103.73 Cr
Others
1.88%
₹21.15 Cr
Healthcare
98.12%
₹1,103.73 Cr
Others
1.88%
₹21.15 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹117.44 Cr
Cipla Ltd.
5.52%
₹62.09 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹52.42 Cr
Procter & Gamble Health Ltd.
4.34%
₹48.82 Cr
Ajanta Pharma Ltd.
4.09%
₹46.01 Cr
Others
70.95%
₹798.10 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹117.44 Cr
Cipla Ltd.
5.52%
₹62.09 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹52.42 Cr
Procter & Gamble Health Ltd.
4.34%
₹48.82 Cr
Ajanta Pharma Ltd.
4.09%
₹46.01 Cr
Others
70.95%
₹798.10 Cr
Funds in this Category
This fund's returns: 24.88%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
28.67
Category Returns
19.31%
28.67%
3Y Returns
28.67 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
25.89
Category Returns
19.31%
28.67%
3Y Returns
25.89 %
Tata India Pharma & HealthCare Fund Direct-Growth
Min. Investment
₹100
23.76
Category Returns
19.31%
28.67%
3Y Returns
23.76 %
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 5.01%, in last 3 years is 94.87% and 586.96% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹1,124.88 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
UTI Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹1,89,171
₹1,94,874
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹94,874
94.87%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk
